Grow | Extract | Retail
Heartland Herbal Healing Biotech operates a 95,000 sq ft licensed U.S. facility authorized to cultivate high-THC medicinal cannabis and produce GMP-grade cannabinoid APIs using advanced extraction technology
Grow | Extract | Retail
150 acres out door cultivation, Extraction & Processing facility, 100,000 sq ft indoor pharmaceutical grade cannabis production.
Advanced cultivation of pharmaceutical-grade high-THC cannabis.
Indoor cultivation technologies engineered to maintain strict pharmaceutical quality standards
Advanced extraction technology and API manufacturing to USA pharmaceutical standards.
Turning APIs into life-changing treatments
GROW
Utilizes advanced indoor hydroponic cultivation within a fully controlled environment to ensure consistent pharmaceutical-grade quality
A unique cultivation facility designed to meet the highest industry standards, including Good Agricultural and Collection Practices (GACP)
Phase 1 cultivation facilities are scheduled to be completed August 2026, with ongoing expansion planned to support a growing portfolio of medicines
Our facilities will be fully integrated to manage the entire cultivation life cycle, from tissue culture and growth to harvest, processing, and API production
Will Be Designed with cutting-edge technology such as smart lighting, environmental automation, hydroponics, and real-time inventory monitoring
Learn more about Heartland Herbal Healing Biotech technology
Extract
Heartland Herbal Healing Biotech utilizes proprietary extraction technology to produce high-quality cannabinoid active pharmaceutical ingredients (APIs), positioning the company among a select group of global manufacturers capable of delivering pharmaceutical-grade, high-THC APIs under stringent USA pharmaceuticals standards.
The API manufacturing process is managed by dedicated in-house production and quality teams, ensuring rigorous quality control, consistency, and compliance with the highest pharmaceutical industry standards.
Retail
OMMA Oklahoma Cannabis licensing will enables Heartland Herbal Healing Biotech to supply pharmaceutical-grade high THC APIs to the global market for the development of advanced cannabinoid medicines. It also supports the company’s ability to utilize its APIs in creating proprietary finished formulations for clinical research, regulated medical distribution, and commercial therapeutic applications.
This regulatory milestone further strengthens the company’s position as a strategic partner for leading pharmaceutical organizations seeking to develop cannabinoid-based treatments, including THC, CBD, and other novel compounds.
The license unlocks multiple commercial pathways, including:
- Supplying high-quality APIs for pharmaceutical drug development
- Manufacturing proprietary finished cannabinoid medicines
- Forming strategic partnerships with global pharmaceutical
leaders
